Table 3: Summary of treatment-emergent adverse events.
|
|
2.5 Million cells/kg |
5 Million cells/kg |
||
|
System Organ Class (SOC) |
Cell Events (Patients) |
Control Events (Patients) |
Cell Events (Patients) |
Control Events (Patients) |
|
Treatment Emergent Adverse Events |
43 (5) |
26 (6) |
32 (6) |
13 (6) |
|
Blood and lymphatic system disorders |
1 (1) |
- |
1 (1) |
- |
|
Anaemia |
1 (1) |
- |
1 (1) |
- |
|
Endocrine disorders |
1 (1) |
- |
- |
- |
|
Adrenal insufficiency |
1 (1) |
- |
- |
- |
|
Gastrointestinal disorders |
17 (4) |
9 (4) |
10 (4) |
3 (3) |
|
Constipation |
4 (2) |
2 (1) |
- |
1 (1) |
|
Vomiting |
1 (1) |
1 (1) |
2 (1) |
1 (1) |
|
Abdominal pain |
4 (1) |
1 (1) |
1 (1) |
- |
|
Nausea |
2 (2) |
- |
1 (1) |
- |
|
Abdominal pain upper |
1 (1) |
- |
2 (1) |
- |
|
Ascites |
2 (1) |
1 (1) |
- |
- |
|
Diarrhoea |
- |
1 (1) |
2 (1) |
- |
|
Haematochezia |
1 (1) |
1 (1) |
- |
- |
|
Abdominal distension |
- |
- |
1 (1) |
- |
|
Aphthous stomatitis |
- |
- |
- |
1 (1) |
|
Gastric ulcer |
- |
1 (1) |
- |
- |
|
Haematemesis |
- |
- |
1 (1) |
- |
|
Haemorrhoids |
- |
1 (1) |
- |
- |
|
Rectal prolapse |
1 (1) |
- |
- |
- |
|
Stomatitis |
1 (1) |
- |
- |
- |
|
General disorders and administration site
conditions |
9 (4) |
5 (2) |
3 (3) |
5 (2) |
|
Pyrexia |
4 (2) |
4 (2) |
1 (1) |
4 (2) |
|
Oedema peripheral |
2 (2) |
1 (1) |
1 (1) |
1 (1) |
|
Chest pain |
1 (1) |
- |
- |
- |
|
Disease progression |
1 (1) |
- |
- |
- |
|
Fatigue |
- |
- |
1 (1) |
- |
|
Non-cardiac chest pain |
1 (1) |
- |
- |
- |
|
Hepatobiliary disorders |
- |
- |
1 (1) |
- |
|
Hepatic cirrhosis |
- |
- |
1 (1) |
- |
|
Infections and infestations |
4 (2) |
2 (2) |
7 (4) |
2 (2) |
|
Nasopharyngitis |
- |
1 (1) |
- |
1 (1) |
|
Urinary tract infection |
- |
1 (1) |
1 (1) |
- |
|
Cellulitis |
- |
- |
1 (1) |
- |
|
Peritonitis bacterial |
2 (1) |
- |
- |
- |
|
Bacteraemia |
- |
- |
1 (1) |
- |
|
Bronchopneumonia |
- |
- |
1 (1) |
- |
|
Herpes virus infection |
1 (1) |
- |
- |
- |
|
Infectious pleural effusion |
- |
- |
1 (1) |
- |
|
Pyelonephritis |
- |
- |
1 (1) |
- |
|
Sepsis |
- |
- |
1 (1) |
- |
|
Subcutaneous abscess |
- |
- |
- |
1 (1) |
|
Typhoid fever |
1 (1) |
- |
- |
- |
|
Investigations |
2 (2) |
3 (1) |
- |
- |
|
Urine output decreased |
2 (2) |
- |
- |
- |
|
Blood bilirubin increased |
- |
1 (1) |
- |
- |
|
International normalized ratio increased |
- |
1 (1) |
- |
- |
|
Prothrombin time prolonged |
- |
1 (1) |
- |
- |
|
Metabolism and nutrition disorders |
1 (1) |
2 (2) |
- |
- |
|
Diabetes mellitus |
- |
2 (2) |
- |
- |
|
Hyperkalaemia |
1 (1) |
- |
- |
- |
|
Musculoskeletal and connective tissue disorders |
3 (2) |
1 (1) |
- |
- |
|
Arthralgia |
2 (1) |
1 (1) |
- |
- |
|
Muscle spasms |
1 (1) |
- |
- |
- |
|
Nervous system disorders |
3 (3) |
- |
3 (2) |
2 (1) |
|
Hepatic encephalopathy |
2 (2) |
- |
3 (2) |
1 (1) |
|
Loss of consciousness |
- |
- |
- |
1 (1) |
|
Paraesthesia |
1 (1) |
- |
- |
- |
|
Psychiatric disorders |
- |
1 (1) |
- |
- |
|
Abnormal behaviour |
- |
1 (1) |
- |
- |
|
Insomnia |
- |
- |
- |
- |
|
Renal and urinary disorders |
1 (1) |
- |
2 (2) |
- |
|
Haematuria |
- |
- |
1 (1) |
- |
|
Renal failure |
- |
- |
1 (1) |
- |
|
Renal failure acute |
1 (1) |
- |
- |
- |
|
Reproductive system and breast disorders |
- |
1 (1) |
- |
- |
|
Gynaecomastia |
- |
1 (1) |
- |
- |
|
Respiratory, thoracic and mediastinal disorders |
1 (1) |
1 (1) |
4 (2) |
1 (1) |
|
Cough |
- |
1 (1) |
1 (1) |
1 (1) |
|
Hydrothorax |
- |
- |
1 (1) |
- |
|
Pleural effusion |
1 (1) |
- |
- |
- |
|
Pneumonitis |
- |
- |
1 (1) |
- |
|
Tachypnoea |
- |
- |
1 (1) |
- |
|
Skin and subcutaneous tissue disorders |
- |
1 (1) |
- |
- |
|
Acne |
- |
1 (1) |
- |
- |
|
Eczema |
- |
- |
- |
- |
|
Vascular disorders |
- |
- |
1 (1) |
- |
|
Artery dissection |
- |
- |
1 (1) |
- |